Blueprint Medicines Corporation (0HOJ.L) LSE

129.40

+0.055(+0.04%)

Updated at July 17 07:31PM

Currency In USD

Valuation

Market Cap5.48B
Enterprise Value5.85B
P/E Ratio-52.87
PEG Ratio0.38
Price/Sales Ratio14.87
Price/Book Ratio24.07
Enterprise/Revenue14.87
Enterprise/EBITDA-63.8

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.28
Operating Margin-0.31

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.49

Income Statement

Revenue508.82M
Revenue/Share8.84
Gross Profit488.66M
EBITDA19.23M
Net Income-67.09M
Diluted EPS-1.07

Balance Sheet

Total Cash576.24M
Total Cash/Share9.06
Total Debt122.75M
Total Debt/Equity0.36
Current Ratio2.8
Book Value Per Share5.38

Price History

52-Week Change36.16
52-Week High129.44
52-Week Low42.68
Moving Average 50 Days85.09
Moving Average 200 Days68.07

Statistics

Average Volume276
Shares Outstanding48.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A